A combination drug has been developed that controls both tumor growth and metastasis, a mouse study has shown. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase inhibitor, the drug controls angiogenesis, limiting a tumor's ability to grow and spread.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/l...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/l...